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Abstract
Background: Pregnant women and their newborns have an increased risk of developing severe influenza and
influenza-related complications. In Germany, seasonal influenza vaccination is recommended for pregnant women
since 2010. However, little is known about pregnant women’s vaccination-related knowledge and attitudes, as
well as their risk perceptions. This study therefore assessed pregnant women’s vaccination-related knowledge,
risk perceptions related to influenza disease and influenza vaccination during pregnancy, and aimed to identify
determinants of influenza vaccination uptake during pregnancy in Germany.
Methods: Between 2012 and 2014, a nationwide web-based prospective cohort study with follow-up interviews
was conducted in initially pregnant women who gave birth over the study period. Control groups were set up in a
cross-sectional fashion during the follow-up interviews. Women who participated in both, the baseline interview
before giving birth and in the 1st interview after giving birth were included in the analysis. Univariate and multiple
logistic regression were used to identify associations between influenza vaccination uptake and sociodemographic
characteristics as well as items assessing attitude and knowledge.
Results: In total, 838 women were included in the analyses. Pregnant women had a positive attitude towards
vaccination in general, but only modest vaccination knowledge. Overall, 10.9 % of women were vaccinated against
seasonal influenza during pregnancy. While pregnant women perceived classical childhood diseases to be more
risky than the respective vaccinations, this relation reversed for influenza: The risk of vaccination was perceived
higher than the risk of the disease. These two types of risk perceptions independently determined influenza
vaccination uptake—higher perception of disease risk and lower perceptions of vaccination-related risks increased
uptake. Additionally, knowledge about the vaccination recommendation for pregnant women and a positive
gynaecologist’s attitude towards vaccination during pregnancy influenced the uptake significantly.
Conclusions: Influenza vaccination uptake in pregnant women is low in Germany. Tailored communication
strategies for pregnant women should focus especially on changing the perceptions of personal risks regarding
influenza and influenza vaccination during pregnancy. Gynaecologists should be made aware about their crucial
role in supporting vaccination decision-making of pregnant women and the need to provide relevant information
to counteract misconceptions.
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Background
Pregnant women and their newborns have an increased
risk of developing severe influenza and influenza-
related complications [1–3]. Influenza during preg-
nancy can cause stillbirth, preterm delivery, and growth
retardation in the child [4, 5]. Therefore, the World
Health Organization and National Immunization Tech-
nical Advisory Groups in many industrialized countries
recommend seasonal influenza vaccination for pregnant
women [6–8].
In Germany, seasonal influenza vaccination is recom-
mended for all pregnant women from the 2nd trimester
and for pregnant women with underlying chronic dis-
ease from the 1st trimester since August 2010 [9]. There
is no other vaccination that is officially recommended
during pregnancy in Germany as of today.
Similar to other European countries [7], a cross-
sectional study in Germany showed low (16 %) seasonal
influenza vaccine uptake among pregnant women for
the 2012/13 influenza season [10]. Major reasons for
being unvaccinated were a lack of confidence in the
vaccine and the perception that vaccination was not ne-
cessary. Beyond these reasons, it is important to also
assess the predictive validity of risk perceptions as well
as attitudes and vaccine-related knowledge, as these
have proven influential determinants of the individual
vaccination decision (overview see [11]). Such data are
crucial for developing tailored communication strat-
egies to improve influenza vaccination coverage in this
at-risk group [12]. However, too little is currently
known about pregnant women’s attitudes and percep-
tions related to vaccination during pregnancy in
Germany.
The present study aimed at closing this gap. Between
2012 and 2014 we carried out a nationwide prospective
cohort study in primigravida pregnant women who gave
birth over the study period, with cross-sectional control
groups at follow-up interviews. The longitudinal part of
the study aimed at assessing changes in vaccination-
related behaviour, attitudes, knowledge and risk percep-
tions that could occur from pregnancy to early mother-
hood. Here we present results from a sub-analysis on
the risk perception and attitudes related to influenza and
seasonal influenza vaccination during pregnancy. Spe-
cifically, this sub-analysis had the objectives to (i) assess
knowledge related to vaccinations in general, (ii) com-
pare risk perceptions related to influenza vaccination
during pregnancy with risk perceptions related to clas-
sical childhood vaccinations from a pregnant woman’s
perspective, (iii) estimate influenza vaccination coverage
in pregnant women in 2011/12 and 2012/13, (iv) investi-
gate reasons for not being vaccinated against seasonal
influenza, and (v) identify further determinants of influ-
enza vaccination uptake during pregnancy.
Methods
Study design and population
Between February 2012 and August 2014, we conducted
a nationwide web-based prospective cohort study in ini-
tially pregnant women who gave birth over the study
period. We collected data at recruitment during preg-
nancy, and followed up on this three more times until
the child was 14 months. To identify possible learning
effects through study participation, control groups were
set up in a cross-sectional fashion during the follow-up
interviews. Those belonging to the longitudinal group
were surveyed 3 more times after giving birth to their
child (+3, +6, and +14 months after childbirth), whereas
women of the control groups were surveyed only once
again (+3, +6, or +14 months after childbirth). The
timing of the follow-up interviews was based on the
vaccination schedule of the German Standing Committee
of Vaccination (STIKO) [13]. Inclusion criteria for study
participation (both for women in the longitudinal group
and the cross-sectional control groups) were (i) being at
least 18 years of age, (ii) pregnant, (iii) primigravida, and
(iv) living in Germany.
At study entry (between February and August 2012),
all pregnant women completed an online study ques-
tionnaire and were subsequently randomly assigned to
either the longitudinal group or to one of the three con-
trol groups. For this sub-analysis we included women
who participated both at study entry before giving birth
and in the 1st interview after giving birth, where ques-
tions related to influenza and influenza-vaccination were
asked (either +3, +6 or +14 months after giving birth;
see Fig. 1). Participants who completed the question-
naires in a very short time (defined as <360 s) were ex-
cluded to improve data quality. Due to the length of the
questionnaire this time-limit was estimated to be the
minimum time for serious participation. Women who
took part in the study twice were identified by cross-
checking the personal codes as well as email addresses
for doublets to reduce the possibility of repeat participa-
tion. Datasets with the same codes or email addresses
were both eliminated from the data set.
Study participants were recruited via different websites
and information portals targeting pregnant women. As
an incentive for study participation, at recruitment
women were enrolled in an online lottery draw for
vouchers worth €20 each. Additionally, women belong-
ing to the longitudinal group received vouchers worth
€10 for participation in follow-up interview at +3 months
after childbirth and women of the control group took
part in a lottery draw for vouchers worth €20 each. To
register for the study, women were asked to provide
their email address that was only used for invitation and
reminders (up to 2 times) to participate in the study as
well as for the lottery draw and distribution of vouchers.
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According to a sample size calculation, 843 pregnant
women were needed to detect possible differences of at
most 3 % from an assumed vaccination coverage of 10 %
(9 % were vaccinated against pandemic influenza in
2009/10 in this target group [14]) with a confidence
interval of 95 % and a power of 80 %. Since seasonal influ-
enza vaccination uptake during pregnancy was not sur-
veyed at the time of recruitment but during the first
interview after giving birth (i.e. either +3, +6 or +14 months
after giving birth), we considered a possible dropout of
approximately 30 % leading to 1,200 pregnant women who
should be recruited.
Questionnaire
We used structured online questionnaires to collect in-
formation on (i) general vaccination-related attitude and
knowledge, prior experiences with vaccinations as well
as the preference for conventional or alternative medi-
cine, (ii) risk perceptions of vaccine-preventable diseases
and the respective vaccinations, (iii) behaviour, attitudes
and knowledge related to influenza disease and seasonal
influenza vaccination, and (iv) sociodemographic factors.
Items of (i), (ii) and (iv) were asked at recruitment and
items of (iii) were surveyed at the first follow-up inter-
view after recruitment. All questions were self-reported
and not validated.
Attitude towards vaccination and general vaccination
knowledge
For our analysis, independent from belonging to the lon-
gitudinal or control group, all the following information
were collected at recruitment: Participants rated their
general vaccination-related attitude and experience on a
scale from 1 (“totally against vaccination” and “very
negative”, respectively) to 100 (“totally in favour of
vaccination” and “very positive”, respectively). General
knowledge about vaccination was assessed using the
knowledge test developed by Zingg and Siegrist [15],
addressing the most prevalent misconceptions about
vaccination. The scale comprises 9 true-false statements.
Women rated all statements as “true”, “false”, or “don’t
know”. General knowledge was calculated as the sum
Fig. 1 Flowchart indicating the number of total participants and their assignment into different subgroups
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score of all correct answers (range 0–9). “Don’t know”
answers were defined as wrong responses [15]. The
higher the score, the greater the correct knowledge is.
To measure the general preference for conventional or
alternative medicine, women were asked on a scale from
1 to 100 whether they would rather consult an alterna-
tive practitioner or a conventional doctor if being sick
(“1” consulting an alternative practitioner vs. “100” con-
sulting a doctor). Moreover, participants rated their
gynaecologist‘s attitude towards vaccination during
pregnancy and their midwife’s attitude towards vaccin-
ation on a scale from 1 (“contra vaccination”) to 100
(“pro vaccination”). In contrast to the previous informa-
tion, these two items were collected at the first follow-
up interview after recruitment.
Risk perception
Risk perception was assessed at recruitment for the
following vaccine-preventable diseases and the respective
vaccinations: (i) seasonal influenza for pregnant women,
and (ii) varicella, measles, pneumococcal disease (de-
scribed as responsible for pneumonia), tetanus, pertussis,
and hepatitis B infection for the child. To assess risk
perceptions, women rated their perceived probability of
acquiring the disease and probability of side effects follow-
ing vaccination (range “0” to “100 %”), as well as for the
perceived severity of the disease and perceived severity of
vaccination side effects (range 1 to 100: “not serious” to
“very serious”). Since perceived risk is a function of the
perceived probability of an event and its expected conse-
quences, we measured the perceived risk as the mathem-
atical product of the perceived probability of acquiring the
disease and perceived disease severity [16]. After multipli-
cation we fit the ranges to 0.01 to 100. While the risk
assessment of influenza referred to the disease and vaccin-
ation during pregnancy, all other diseases and vaccinations
referred to their future child.
Influenza vaccination
All women answered the following influenza vaccination-
related questions at the first follow-up after recruitment,
which was 3+ months after giving birth for the longitu-
dinal group and at either 3+, 6+ or 14+ months after
giving birth for the control groups. Influenza vaccination
uptake was defined as having received a flu shot during
pregnancy. Unvaccinated women were asked to express
their reasons for not getting vaccinated by selecting from
a predefined set of possible answers (multiple answers
possible). Furthermore, knowledge of STIKO vaccination
recommendations during pregnancy was surveyed.
Women were asked to state which of the following
vaccinations (tetanus, influenza, rotavirus, hepatitis B)
were recommended by the STIKO for pregnant women.
After providing their responses, participants were pro-
vided with the correct answer (influenza).
Sample characteristics
For sociodemographic factors, at recruitment we col-
lected data on age, country of birth, place of residence,
education level, employment status, and monthly house-
hold income. Pregnancy trimester at the time of recruit-
ment was calculated based on the date of recruitment
and the expected date of birth.
Statistical analysis
We performed descriptive statistics to describe the study
population, general vaccination-related knowledge, risk
perceptions among pregnant women, and reasons for
not being vaccinated against influenza during pregnancy.
To analyse the association between vaccination-related
knowledge and sociodemographic variables we calcu-
lated Spearman correlation coefficient. To determine
potential associations between influenza vaccination up-
take and sociodemographic characteristics as well as atti-
tude and knowledge items, we conducted univariate and
multiple logistic regression analyses. Odds ratios (OR)
and 95 % confidence intervals (CI) were calculated. A
p-value of <0.05 was considered statistically signifi-
cant. Variables with a p-value of <0.1 in the univariate
analysis were entered in the first step of the multiple
analyses. We then removed non-significant factors
(≥0.05) from the model in a stepwise backward pro-
cedure to obtain the final model. Missing data were
not replaced or imputed. Statistical analyses were per-
formed with StataSE13 (StataCorp LP, College Station,
TX, USA).
Ethical considerations and data protection
Participants were informed about study details, including
data protection and privacy issues. Participation in the
study was only possible after the women provided an
informed consent via the online questionnaire. All data
were collected and analysed anonymously. Emails for the
lottery draw and distribution of vouchers were tech-
nically separated from the data of the questionnaire. The
study was approved by the ethics committee of Charité
University Medicine, Berlin (Charité, EA1/010/12).
Results
Recruitment and sample characteristics
In total 1,366 pregnant women qualified for the study
and completed the recruitment questionnaire. Of these,
916 women also participated in the 1st interview after
giving birth, where questions related to influenza and
influenza-vaccination were asked. Since 78 participants
completed the questionnaires in a very short time, they
were excluded from the dataset, resulting in 838 women
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included in the final analyses (Fig. 1). All surveyed
women were pregnant during influenza seasons in 2011/
12 or 2012/13. An overview of participants’ characteris-
tics compared to the general female population aged
18–49 years living in Germany is shown in Table 1. The
median age of participants was 30 years (range 18–42).
More than three quarters of women had an university
entrance diploma and more than half of women were at
the time of study enrolment in their 3rd trimester of
pregnancy.
Attitude towards vaccination in general
Overall, pregnant women had a positive general
vaccination-related attitude (mean: 81.5, 95 % CI
80.0–83.0). However, women rated their gynaecolo-
gist’s attitude towards vaccination during pregnancy
(mean: 66.0, 95 % CI 63.6–68.4) and their midwife’s
attitude towards vaccination in general as rather mod-
erate (mean: 60.8, 95 % CI 58.5–63.1).
General vaccination knowledge
Participants’ answers to the items of the vaccination
knowledge test are presented in Table 2. Overall, general
vaccination knowledge was moderate in pregnant women.
Half of them stated at least six correct answers (median: 6;
range: 0–9; mean: 5.8, 95 % CI 5.6–5.9). Almost all preg-
nant women knew that vaccinations are not superfluous.
The majority also stated that the efficacy of vaccines has
been proven and that massive vaccination programs are
important to eliminate specific diseases.
However, many pregnant women were unsure in
responding to other items, leading to a high percentage
of participants quoting “don’t know” as an answer. For
example, 40 % of women did not know that the immune
system of children will not be overwhelmed by a high
number of vaccines. Moreover, almost one quarter of
participants believed that additives used in vaccines are
dangerous and that many vaccinations are administered
too early.
Age and education level were significantly associated
with knowledge (r = .10, p < 0.05 for both variables), indi-
cating that pregnant women with an increased age and
with higher education level had a better general know-
ledge about vaccination. There were no significant rela-
tions to other socio-demographic variables.
Risk perception
Figure 2 shows the means of perceived risks of vaccine-
preventable diseases and the respective vaccinations
among pregnant women. The highest disease-specific
risks were considered for an infection with tetanus,
measles and pneumococcal disease for children in their
lifetime. Varicella vaccination was assigned the lowest
perceived risk compared to other vaccinations. For
children the perceived risk of the disease was always
rated significantly higher than the perceived risk of the
vaccination. However, this pattern reversed for percep-
tions related to influenza vaccination during pregnancy:
influenza vaccination during pregnancy was perceived
Table 1 Characteristics of study population at recruitment and
the general female population aged 18–49 years living in
Germany in 2012
Characteristics Study population,




Age-group (n = 836)
18–24 years 9.0 18.4
25–29 years 33.7 14.4
30–34 years 41.6 14.7
35–39 years 14.4 18.3
40–49 years 1.3 20.3
Country of birth (n = 838)
Germany 94.8 82.2
Other country 5.3 17.8
Place of residenceb (n = 838)
Eastern Federal States 27.2 18.7
Western Federal States 72.8 81.3




Employment (n = 837)
Not employed 16.1 25.7
Part-time employed 11.8 32.2
Full-time employed 72.0 42.1
Monthly household income
(n = 826)
≤ 1500 € 10.4 18.4
1501–2000 € 11.9 11.1
2001–2500 € 14.3 59.2
2501–3000 € 17.1
≥ 3001 € 46.4




aData from the microcensus 2012 from the Federal Statistical Office of
Germany [48]. Since data concerning household income and education level
was not available for each women, data cannot result in 100 % ; bEastern
Federal States: Mecklenburg-Vorpommern, Brandenburg, Berlin, Saxony,
Saxony-Anhalt, Thuringia; Western Federal States: Schleswig-Holstein, Bremen,
Hamburg, Lower Saxony, Hesse, Rhineland-Palatinate, Saarland, North Rhine-
Westphalia, Bavaria, Baden-Württemberg; cLow: nine years or less of school
education, middle: at least 10 years of school education, high: university
entrance diploma
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significantly more risky than acquiring an influenza virus
infection during pregnancy.
Influenza vaccination and reasons for not being
immunized
Influenza vaccination status was available for almost all
participants (99.6 %). Overall, 91 women (10.9, 95 % CI
8.9–13.2) stated that they had received a seasonal influ-
enza vaccination during pregnancy: 18 (19.8 %) in their
1st, 47 (51.7 %) in their 2nd and 26 (28.6 %) in their 3rd
trimester of pregnancy.
The most frequently stated reasons for not having re-
ceived an influenza vaccination were the perception that
vaccination is not necessary, lacking awareness of the
influenza vaccination recommendation for pregnant
women, and mistrust in the vaccine (Fig. 3). Among
unvaccinated women, those who did not know the
vaccination recommendation stated in 37.2 % that the
vaccination is not necessary, whereas those who did not
mention absent knowledge of the vaccination recom-
mendation as a reason for being unvaccinated stated in
63.9 % that vaccination is not necessary (p < 0.001).
Independent of their vaccination status, about half of all
participants (54.4, 95 % CI 51.0–57.8) were aware and
45.6 % (95 % CI 42.2–49.0) were not aware of the STIKO
recommendation in respect to vaccination of pregnant
women against seasonal influenza. However, many women
incorrectly thought that STIKO recommends pregnant
Table 2 General vaccination knowledge of 838 pregnant women, Germany 2012
Item Statement Response [%]
Correct Incorrect Don’t know
1 The additives used in vaccines are not dangerous for humans (true) 43.4 23.2 33.4
2 Diseases like autism, multiple sclerosis, and diabetes might be triggered by vaccinations (false) 58.2 7.5 34.3
3 Vaccinations increase the occurrence of allergies (false) 58.1 12.1 29.8
4 Vaccines are superfluous, as diseases can be treated, e.g. with antibiotics (false) 94.8 1.8 3.5
5 Without massive vaccination programs, smallpox would still exist (true) 81.0 4.4 14.6
6 The efficacy of vaccines has been proven (true) 87.7 4.5 7.8
7 Children would be more resistant if they were not always vaccinated against all diseases (false) 63.6 16.0 20.4
8 Many vaccinations are administered too early. As a result, the body’s own immune system has
no possibility to develop by itself (false)
45.5 20.2 34.4
9 The immune system of children will not be overwhelmed by a high number of vaccines (true) 44.9 15.5 39.6
Knowledge test developed by [15]
Fig. 2 Perceived risk* of vaccine-preventable diseases and the corresponding vaccinations among pregnant women, Germany, 2012
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women also vaccination against tetanus (38.9, 95 % CI
35.6–42.3), hepatitis B (33.8, 95 % CI 30.6–37.1), hepatitis
A (21.7, 95 % CI 19.0–24.7), and rotavirus (11.5, 95 % CI
9.4–13.8). When asking vaccinated women how they were
advised of the influenza vaccination, almost all partici-
pants mentioned their physician (90.1, 95 % CI 82.1–95.4)
followed by family and friends (17.6, 95 % CI 10.4–27.0).
The majority of vaccinated women stated their physician
as an important source of information about influenza
vaccination during pregnancy (85.7, 95 % CI 76.8–92.2),
followed by the Internet (23.1, 95 % CI 14.9–33.1) and
family and friends (13.2, 95 % CI 7.0–21.9). Print media
was only mentioned by 6.6 % (95 % CI 2.5–13.8).
Factors associated with influenza vaccination uptake
Table 3 presents the results of univariate and multiple
logistic regression analyses of factors influencing influ-
enza vaccination uptake in pregnant women. Influenza
vaccination uptake was independently associated with
the knowledge of the influenza vaccination recommen-
dation for pregnant women, a higher perceived gynae-
cologist’s attitude towards vaccination during pregnancy,
and an increased perceived risk of influenza infection; it
was negatively associated with an increased perceived
risk of influenza vaccination. Knowledge and attitudes
related to vaccination in general were not independently
associated with influenza vaccination uptake.
Discussion
Pregnant women are at increased risk for severe influ-
enza and constitute a target group for seasonal influenza
vaccination in Germany since 2010. In our study popula-
tion, vaccination uptake of 11 % during the 2011/12 and
2012/13 influenza season was suboptimal, which calls
for an enhancement of activities to improve influenza
vaccination coverage in this at-risk group in Germany.
Among study participants, women possessed a medium
level of vaccine-related knowledge and had a positive at-
titude towards vaccination in general. The perceived
risks of childhood diseases were always rated higher than
the perceived risk related to the respective vaccine.
However, for influenza the perceived risk of suffering
from side effects after influenza vaccination during preg-
nancy was higher than of contracting influenza.
In a recently published cross-section survey conducted
in Germany during the 2012/13 influenza season, an
equally low seasonal influenza vaccination coverage
(16, 95 % CI 13.7–18.4) was identified among pregnant
women [10]. In that study, a different study design and
participant recruitment was applied (i.e. cross-sectional
study where pregnant women were recruited based on a
special sampling frame [ADM-Sampling-System for
Face-to-Face Surveys] designed as an area sample), which
allowed the assembly of a representative sample for
Germany. A recent published review summarized vaccin-
ation rates among pregnant women in various indus-
trialized countries ranging from 2 to 88 % [17]. These
substantial differences between countries might be ex-
plained by different communication activities supporting
the vaccination recommendations, differences in vaccin-
ation systems and funding schemes, and also in different
attitudes related to seasonal influenza vaccination.
In our study we were able to show that the knowledge
of the influenza vaccination recommendation during preg-
nancy, the vaccination-related attitude of the gynae-
cologists, and risk perceptions play a major role in the
pregnant women’s influenza vaccination decision-making
process. Findings of other studies revealed that health care
Fig. 3 Reasons against seasonal influenza vaccination stated by 744 unvaccinated women, Germany (multiple answers were allowed)
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providers were more likely to recommend vaccination if
they have a positive attitude towards influenza vaccination
during pregnancy [18–20]. This finding was confirmed in
a study among occupational physicians in Germany,
where an association between a positive attitude towards
vaccination and a higher likelihood of recommending in-
fluenza vaccination to pregnant women was identified
[21]. According to the review of Yuen et al. [17], pregnant
women were 20 to 100 times more likely to receive the flu
shot when being advised of the vaccination by a health
care provider. We found that in addition to physicians the
Internet was also mentioned as an important source of in-
formation about influenza vaccination. However, vaccine-
related information from the Internet must be considered
with caution since misconceptions about vaccination are
prevalent and could influence the perceived risk of vaccin-
ation and the intention to vaccinate [22, 23].
In our study, the most commonly stated reasons
against having received a flu shot were the absent know-
ledge of the vaccination recommendation but also a per-
ception of being at low risk for acquiring influenza. This
indicates that communication strategies will fall short if
only focusing on making pregnant women acquainted
with the existence of the recommendation. In fact, there
is a need for high-quality patient education to make
women aware of the importance of vaccination and the
safety of flu vaccines during pregnancy. Other studies
also indicated that pregnant women were insufficiently
informed about the risk of influenza during pregnancy
and the benefits of vaccination [10, 17, 24–26]. A study
from the US found for example that only 23 % of preg-
nant women compared to 35 % of non-pregnant women
stated being at risk for vaccine-preventable diseases [27].
When rating the perceived risks of different diseases and
the respective vaccinations, our findings showed the
highest perceived risk for infections that refer to chil-
dren. Among those diseases, pregnant women perceived
the lowest risks for hepatits B, pertussis and varicella.
This perception is also reflected in the national vaccin-
ation coverage estimates from school entrance examina-
tions in Germany, that show a lower uptake of hepatitis
B and varicella vaccines when compared to other vac-
cines such as measles, tetanus, pertussis or polio [28].
As a major finding, we identified a reversed risk per-
ception regarding the infection with influenza and influ-
enza vaccination during pregnancy, leading to a higher
risk perception of the vaccination compared to the
disease. The lack of an appropriate influenza risk per-
ception among pregnant women is alarming and must
be considered in tailoring communication strategies that
ideally are directed at the factors that impede vaccin-
ation [12]. The results of our study demonstrate that it
Table 3 Factors potentially associated with influenza vaccination uptake during pregnancy, Germany
Factor Vaccination coverage, %a Univariate OR (95 % CI)a Multiple OR (95 % CI)b
Age-group
18–24 years 4.0 Ref. NS
25–29 years 12.8 3.53 (1.06–11.79)
30–34 years 10.7 2.87 (0.86–9.58)
35–39 years 11.7 3.17 (0.88–11.43)
40–49 years 9.1 2.4 (0.23–25.36)
Knowledge of STIKO-recommendation during pregnancy
Yes 18.2 10.38 (4.95–21.74) 8.0 (3.35–19.12)
No 2.1 Ref. Ref.
Preference for conventional or alternative medicine − 1.02 (1.00–1.03) NS
Prior experiences with vaccinations – 1.02 (1.01–1.03) NS
General vaccination knowledge – 1.32 (1.18–1.48) NS
General vaccination-related attitude – 1.03 (1.02–1.05) NS
Gynaecologist’s attitude towards vaccination during pregnancy – 1.04 (1.03–1.06) 1.04 (1.03–1.06)
Midwife’s attitude towards vaccination in general – 1.01 (1.00–1.02) NS
Perceived risk of influenza infection – 1.04 (1.03–1.05) 1.05 (1.03–1.06)
Perceived risk of influenza vaccination – 0.96 (0.95–0.97) 0.97 (0.96–0.98)
BIC −128.84
Cragg & Uhler's R2 0.45
Other nonsignificant variables in univariate analysis (p ≥ 0.1) were: country of birth, place of residence, education, number of screening examination during pregnancy
NS not significant; Ref reference category
aIncluded participants with information on relevant item; bIncluded n = 495 participants with complete information on all items
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is necessary to focus on changing the perceptions of per-
sonal risks regarding the disease and the vaccination
during pregnancy [11]. Independent of the vaccination
and population, studies showed that risk perception is a
main predictor of vaccination behaviour and that
immunization decisions are strongly influenced by emo-
tional factors [29–34]. In this respect, we were also not
able to find any association between general vaccination
knowledge and influenza vaccination uptake in pregnant
women. Our data suggest that in the case of influenza
and pregnant women it is the specific knowledge about
vaccination during pregnancy that relates to the vac-
cination decision. Also the general attitude towards
vaccination did not influence the influenza vaccination
decision. We assume that this attitude is a result of an
evolving process that is formed particularly after making
the first vaccination experiences with the own child,
acting on the assumption that the general vaccination
attitude of mothers and pregnant women normally is
unimpaired and overall good. Similar to our results, a
Canadian study among mothers of young children indi-
cated a generally positive attitude of vaccinations [35].
In a European project, parents with children less than
3 years of age had generally positive attitudes towards
immunizations in the childhood vaccination programs,
and between 81 and 97 % of parents would immunize
their child in the future [36]. In further investigations
that base on the data of the presented study we will be
able to analyse if the attitude towards vaccination
changes over time and which events or sources of infor-
mation instigate and influence changes in attitudes. For
pregnant women, several studies have demonstrated that
the majority is willing to get vaccinated during
pregnancy if recommended by their health care provider
[27, 37, 38]. In respect to the influenza vaccination,
pregnant women must be educated more specifically
about the benefits and risks of influenza vaccination in
pregnancy not only with a focus on protecting them-
selves but also their child. These findings should be con-
sidered in the national information campaign that is
conducted annually in Germany to raise awareness
about the importance of influenza vaccination and to
increase vaccination uptake in the main target groups
including pregnant women.
Of concern, we found overall moderate vaccination
knowledge in pregnant women. Interventions targeted at
pregnant women should therefore aim at improving in-
fluenza specific and general vaccination-related know-
ledge. Studies from Spain and Germany also identified
several prevalent vaccination-related misconceptions in
parents [39, 40]. It was also shown that the immu-
nization status of children was influenced by vaccination
knowledge of pregnant women and parents [15, 39, 41].
Thus, pregnancy provides a unique opportunity to
educate future parents about immunization. Other study
findings revealed that the vaccine decision-making process
begins prenatally and is an evolving process [29, 42, 43].
Wroe et al. [29] demonstrated that 88 % of women made
the immunization decision for their child antenatally.
Parents of a study conducted in England even suggested
receiving information prior to childbirth to make more in-
formed vaccination decisions [42]. Therefore, the perinatal
period represents an important time for providing edu-
cation about immunizations. Especially gynaecologists
should use the frequent check-ups during antenatal care
for educating pregnant women on the importance of
vaccinations. In Germany, based on a nationwide stan-
dardized program of prenatal care, each pregnant woman
receives an official booklet at the beginning of pregnancy
that comprises all medical check-ups and their results
during pregnancy. However, the need for influenza vaccin-
ation has not been mentioned in this document as of
today, but would be a good opportunity to remind both,
physician and pregnant women, about the importance of
influenza vaccination during pregnancy.
Half of our participants knew about the existence of
the STIKO influenza vaccination recommendation for
pregnant women. However, we must assume that this
proportion is likely an overestimation of the true know-
ledge, since many women incorrectly quoted further
vaccinations that they should receive during pregnancy.
As vaccination appears to be the socially desired answer
it seems that such guesses could be biased in the positive
direction [21]. However, our results and findings from
other studies demonstrated that the correct knowledge
of vaccination recommendation is crucial for vaccination
uptake [17, 44].
Our study has several limitations: (i) Since our study
was an online-based survey we cannot rule out some
degree of selection bias. To compare characteristics of
study population we used data for women of child-
bearing age living in Germany since no representative
national perinatal dataset exists. It turned out that
women born in Germany and women with a higher
education were over-represented in our study. If higher
education is confounded with higher vaccination know-
ledge, this could mean a rather overestimation of the
presented general vaccination knowledge. Thus, repre-
sentativeness of the study sample could not be fully
determined. However, the vaccination coverage estimate
was not substantially different from that identified in a
cross-sectional study conducted in Germany that utilized
a special sampling frame to reach a more representative
sample of the target population [10]. (ii) Due to our re-
cruitment strategy we could not calculate the response
rate, since the total number of pregnant women who
noticed the online request for study participation is
unknown. (iii) Vaccination status was self-reported and
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can therefore be subject to misclassification. While a re-
cently published study suggested an overestimation for
self-reported seasonal influenza vaccination rates com-
pared to vaccination registries [45] other studies revealed
an adequate degree of reliability [46, 47]. (iv) We did not
ask for underlying chronic diseases, even though they
are an indication for receiving the flu shot already
during the first trimester of pregnancy in Germany.
Therefore, we must assume that approximately 20 % of
women stated being vaccinated during their first trimester
of pregnancy either were chronically ill, did not know the
influenza vaccination recommendation or did not know
that they were pregnant when receiving the flu shot. (v)
The sample was limited to German-speaking women as
the online questionnaire was only available in German.
Women who were not able to understand German were
therefore not represented in the study population, which
might have introduced some selection bias.
Conclusions
In conclusion, influenza vaccination uptake in pregnant
women is low in Germany. Further efforts are needed to
promote and educate pregnant women specifically about
the benefits and risks of influenza vaccination during
pregnancy to protect pregnant women and their infants.
Tailored communication strategies for pregnant women
should focus especially on improving perceptions related
to personal risks regarding the disease and the vaccin-
ation. It is concerning, that many pregnant women have
a lack of general vaccination knowledge indicating fur-
ther needs for education about vaccine-related miscon-
ceptions. Gynaecologists should be made aware about
their crucial role in supporting vaccination decision-
making of pregnant women and the need to provide
relevant information to counteract misconceptions.
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